Suchergebnisse - "Mazzoni, Francesca"

PubPharm (14)

1

Inflammation of the retinal pigment epithelium drives early-onset photoreceptor degeneration in Mertk-associated retinitis pigmentosa

enthalten in: Science advances | 2023

von Mercau, M. | Akalu, Y. | Mazzoni, F. | +7

2

In Regard to "Activity of EGFR TKIs in Caucasian Patients With NSCLC Harbouring Potentially Sensitive Uncommon EGFR Mutations"

enthalten in: Clinical lung cancer | 2020

von Caliman, E. | Petreni, P. | Brugia, M. | +2

CommentOn: Clin Lung Cancer. 2019 Mar;20(2):e186-e194. - PMID 30563752

3

Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2020

von Wolf, J. | Seto, T. | Han, J. | +127

4

Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib : A Study on Circulating Cell-free DNA

enthalten in: Clinical lung cancer | 2020

von Del Re, M. | Petrini, I. | Mazzoni, F. | +10

5

Microglia Inhibition Delays Retinal Degeneration Due to MerTK Phagocytosis Receptor Deficiency

enthalten in: Frontiers in immunology | 2020

von Lew, D. | Mazzoni, F. | Finnemann, S.

6

Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non-Small Cell Lung Cancer (METROS) : A Phase II, Prospective, Multicenter, Two-Arms Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Landi, L. | Chiari, R. | Tiseo, M. | +25

CommentIn: Clin Cancer Res. 2020 Apr 1;26(7):1774. - PMID 32238411

7

Clinical evaluation of dacomitinib for the treatment of metastatic non-small cell lung cancer (NSCLC) : current perspectives

enthalten in: Drug design, development and therapy | 2019

von Lavacchi, D. | Mazzoni, F. | Giaccone, G.

8

Afatinib with subsequent surgery in stage III NSCLC with EGFR mutation : Lessons learned from two clinical experiences

enthalten in: Tumori | 2018

von Mazzoni, F. | Petreni, P. | Perna, M. | +5

9

Osteonecrosis of the Jaw and Angiogenesis inhibitors : A Revival of a Rare but Serous Side Effect

enthalten in: Current medicinal chemistry | 2017

von Antonuzzo, L. | Lunghi, A. | Petreni, P. | +7

10

Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2016

von Cappuzzo, F. | Morabito, A. | Normanno, N. | +16